About TULSA Procedure - TULSA Procedure

About the TULSA Procedure

WHAT IS THE TULSA PROCEDURE?

The word ‘TULSA’ stands for Transurethral Ultrasound Ablation. It is a minimally invasive procedure that uses directional ultrasound to produce very high temperatures to ablate (destroy) targeted prostate tissue. The procedure is performed in a Magnetic Resonance Imaging (MRI) suite and uses the TULSA-PRO® system to ablate prostate tissue. The physician can see the prostate at all times throughout the procedure. The procedure combines real-time MRI with robotically-driven directional thermal ultrasound to deliver predictable, physician-prescribed ablation of whole-gland or partial prostate tissue.

The TULSA Procedure is radiation-free, incision-free and FDA approved. The physician can customize the procedure depending on patients’ needs, conditions and desired functional outcomes.

How Does the TULSA Procedure Work?

The TULSA Procedure consists of four (4) stages:

1. Preparation

Before the procedure, the patient will meet his treatment team. Typically, the treatment team includes a treating physician (urologist and/or radiologist), an anesthesiologist, and an Radiology Technologists. The treatment team will ensure the patient is comfortable before sedation.

The patient is then moved into the MRI room where the Ultrasound Applicator (UA) is inserted into the urethra, and the Endorectal Cooling Device (ECD) is inserted into the rectum by the treating physician.

The UA has 10 transducer elements – each one emits ultrasound energy in to the prostate. The physician can individually activate and control each transducer element depending on the prostate size. The UA also cools the urethra, which protects it from the thermal ultrasound energy. In the example below, only 9 out of the 10 transducer elements are needed to target the desired prostate tissue (Figure 1).

Figure 1: The Ultrasound Applicator

The ECD is a passive cooling device that protects the rectal tissue from the thermal ultrasound energy, helping to preserve the patient’s natural functions (Figure 2). There is no energy emitted by ECD.

Once these devices are inserted into the patient, the treatment team is ready for the planning stage.

Figure 2: The Endorectal Cooling Device (ECD)

2. Planning

The TULSA-PRO system is connected to the MRI machine (Figure 3). This enables the physician to use high-precision MR imaging to determine the exact areas of the prostate that will be ablated. Using these MR images, the physician draws out the boundary lines to create the patient’s customized procedure plan, tailored to their individual prostate shape, size and disease, while avoiding important nerve bundles and critical structures around the prostate.

Figure 3: The TULSA Procedure is delivered to the patient by connecting the MRI system with the TULSA-PRO system, which allows the treating physician to use high-precision MR images to clearly see the prostate and draw the appropriate ablation boundary lines around the prostate tissue.

Using high-precision MR imaging, the physician can see the prostate in the axial view (Figure 4a), sagittal view (Figure 4b), and coronal view (Figure 4c). Using these images, the treating physician draws the boundary lines around the prostate section that corresponds to each ultrasound element. For example, in Figure 5, a specific ablation boundary line is drawn for transducer element 4.

Figure 4: The prostate anatomy in the a) axial view, b) side view, and c) coronal view.

Figure 5: The Ultrasound Applicator (UA), the Endorectal Cooling Device (ECD) and the boundary line for Transducer Element 4 in the a) axial, b) sagittal, and c) coronal view.

If the physician is preparing for a whole-gland ablation, they will continue to draw separate ablation boundary lines for the rest of the transducer elements, until the entire targeted prostate tissue region is selected (Figure 6).

Figure 6: Boundary lines for a whole-gland ablation procedure, with transducer elements 1-9 activated, in the a) axial, b) sagittal, and c) coronal view.

If the patient receives a partial gland ablation (for example a hemi ablation), the treating physician can customize the ablation area by drawing boundary lines around only sections of the prostate, and for only a subset of the transducer elements (Figure 7).

Figure 7: Boundary lines for a hemi ablation procedure, with transducer elements 1-5 activated, in the a) axial, b) sagittal, and c) coronal view.

Some patients may be suitable for a nerve sparing plan, and the treating physician can accommodate this using the TULSA Procedure. The treating physician would adjust the ablation boundary lines so they are further away from the neurovascular bundles (Figure 8).

Figure 8: Boundary lines for a nerve sparing procedure, with transducer elements 2-9 activated, in the a) axial, b) sagittal, and c) coronal view.

The treating physician has the control and flexibility to adjust each boundary line depending on the patient’s anatomy (size and shape of prostate), their needs, and where the diseased prostate tissue is.

Now that the boundary lines have been drawn, the treatment team is now ready to begin prostate ablation.

3. Delivery

During prostate ablation, the UA rotates within the urethra, creating a sweeping heating pattern that is directional and ablates the prostate tissue using an inside-out approach.

During the procedure, the TULSA-PRO system automatically carries out the ablation instructions outlined by the physician, ablating only within the prescribed boundary lines using real-time thermal images. The TULSA-PRO system carries out the physician’s treatment plan, which helps ensure precise prostate ablation and minimizes the risk of human error.

Figure 9: In this whole gland ablation, the physician can see the areas of the prostate being ablated in the a) axial view, b) side view, and c) coronal view.

Figure 10: In this hemi ablation, the physician can see the areas of the prostate being ablated in the a) axial view, b) side view, and c) coronal view.

TULSA PRO’s connection to the MRI machine creates a closed-loop thermal feedback system and allows for the physician to see MRI thermometry images in real-time. The real-time MRI thermometry images show the changing temperature of the prostate tissue and surrounding structures every 6 seconds. This visibility allows the physician to actively monitor tissue heating and make changes to the treatment delivery if necessary, making the TULSA Procedure controlled and predictable.

Once ablation is complete, the physician can always go back and deliver additional ablation to the prostate if necessary.

Figure 11: In this nerve sparing ablation, the physician can see the areas of the prostate being ablated in the a) axial view, b) side view, and c) coronal view.

4. CONFIRMATION

Using MR imaging, the physician will confirm the intended areas of the prostate that have been ablated successfully. Once the TULSA Procedure is complete, the patient will be catheterized and monitored during a brief recovery period. Patients are typically able to leave the same day, and resume daily activities.

Figure 12: Magnetic Resonance (MR) Images of a prostate a) before, and b) immediately after the TULSA Procedure.

008-103 immediate posttreatment ax_t1_CROPPED-after

WHO QUALIFIES FOR THE TULSA PROCEDURE?

Patients receiving the TULSA Procedure must be screened by a Magnetic Resonance Imaging professional (Radiology Technologists) before entering the MRI suite and assessed by an anesthesiologist before the procedure. Whether a patient qualifies for the TULSA Procedure will be determined by the treating physician. In previous clinical trials, ideal candidates consisted of men with low and intermediate risk, organ-confined prostate cancer.

Patients should contact a TULSA-PRO expert at a TULSA-PRO Center to know if they qualify for the TULSA Procedure. To find a TULSA-PRO Center near you, click here.

108646B

Find a TULSA Procedure Center

Newsletter Sign Up

Contact Profound Medical

TULSA Procedure^TM | Profound Medical

Global Head Office Locations

Canada

6, 2400 Skymark Avenue
Mississauga, ON
L4W 5K5

United States

359, 9160 Forum Corporate Parkway
Fort Myers, FL
33905

Europe

Germany
Kehrwieder 9, 20457, Hamburg

Finland
Äyritie 4B, 01510, Vantaa

About the TULSA Procedure